fbpx

Diagnosed with SMM, SPB, or MGUS?

Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.

Click the orange button to the right to learn more.

Category Archives for Pre-Myeloma

Treatment vs. Watchful Waiting-Smoldering Multiple Myeloma

“Trials of lenalidomide (revlimid) in a less intensive approach has shown promise in delaying disease progression and should be investigated further in clinical trials.” You’ve been diagnosed

Continue reading

Single Plasmacytoma, MGUS, SMM Demystified

Plasmacytoma, MGUS and SMM Defined- Symptoms, Causes, Diagnostics- Hi. My name is David Emerson. I am a the Director of PeopleBeatingCancer, long-term Multiple Myeloma survivor and Multiple Myeloma cancer

Continue reading

Predicting Overall Survival of Solitary Bone Plasmacytoma

“The multivariable regression analysis was performed to obtain the significant prognosis that was used to establish the nomogram for 3-, 5-, and 10-year OS.” I was diagnosed with a single bone

Continue reading

Chemotherapy for Smoldering Multiple Myeloma???

“Nonhematologic grade 3 adverse events occurred in 21 patients (38.9%) and included thromboembolism, rash, and lung infection, with no grade 4 events.” Yes, chemotherapy can slow the progression

Continue reading

MGUS Dx- Cure vs. Control?

MGUS patients are more likely to develop more severe PN during treatment with certain drugs used to treat MM (e.g. bortezomib and thalidomide) Hi David- I was diagnosed with Monoclonal Gammopathy

Continue reading

Smoldering Multiple Myeloma (SMM) – Chemo now, later?

“New studies (pre-habilitation) suggest that a multimodal approach that incorporates both physical and psychological prehabilitation interventions may be more effective than a unimodal approach that

Continue reading

Pre- Myeloma? Stage 1 Multiple Myeloma? Cure vs. Control

Should we treat patients with myeloma with multidrug, multitransplant combinations with the goal of potentially curing a subset of patients, recognizing that the risk of adverse events and effect on quality

Continue reading

Risk of Progression for Smoldering Multiple Myeloma is Reduced…at what cost?

“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, Monoclonal

Continue reading

Rheumatologic Disease Inc. Risk of MGUS to Multiple Myeloma

“Patients with monoclonal gammopathy of undetermined significance (MGUS) have twice the risk of developing multiple myeloma (MM) if they have non-antibody (Ab)-mediated rheumatic diseases (RDs)…” Rheumatic

Continue reading

MGUS, Myeloma AL Amyloidosis- Conventional, Non-Conventional

“Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement…in multiple myeloma or MGUS patients?” You’ve been diagnosed with multiple myeloma

Continue reading
1 2 3 11